Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer

被引：0
|
作者：
Paola Muti
Giorgio Secreto
Vittorio Krogh
机构：
[1] McMaster Univeristy,Department of Oncology, Faculty of Health Sciences
[2] Fondazione Istituto Nazionale Tumori Milano,undefined
来源：
Breast Cancer Research and Treatment | 2017年 / 163卷
关键词：
Overall Survival; Androgen Receptor; DHEAS; Ovarian Suppression; Estrogen Synthesis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：631 / 632
页数：1
相关论文
共 50 条
  • [41] Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer
    Matteo Lambertini
    Lucia Del Mastro
    Giulia Viglietti
    Noam F. Pondé
    Cinzia Solinas
    Evandro de Azambuja
    [J]. Current Treatment Options in Oncology, 2017, 18
  • [42] Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy
    Sverrisdóttir, A
    Fornander, T
    Jacobsson, H
    von Schoultz, E
    Rutqvist, LE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (18) : 3694 - 3699
  • [43] Ovarian ablation or suppression in premenopausal early breast cancer: Results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial
    Bliss, J. M.
    Johnson, L.
    Lawrence, D.
    Peto, J.
    Price, D.
    Yarnold, J.
    Barrett-Lee, P.
    Brunt, A. M.
    Dodwell, D.
    Earl, H.
    Fernando, I.
    Foster, L.
    George, W. D.
    Harnett, A. M.
    Perren, T.
    Poole, C.
    Raina, V.
    Robinson, A.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (07) : 516 - 525
  • [44] Cost-Effectiveness Analysis of Adjuvant Endocrine Therapy With Ovarian Suppression in Premenopausal Patients With Hormone Receptor-Positive Early Breast Cancer in China
    Zhong, Xiaorong
    Chen, Ping
    He, Ping
    Wu, Yanqi
    Suo, Jiaojiao
    Zhu, Kunrui
    Yan, Xi
    Tian, Tinglun
    Yang, Qing
    Luo, Ting
    [J]. CLINICAL BREAST CANCER, 2024, 24 (02) : e41 - e50
  • [45] Role of Ovarian Suppression in Early Premenopausal Breast Cancer
    Francis, Prudence A.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (01) : 79 - 88
  • [46] Ovarian Function Suppression in Premenopausal Women With Concurrent Endocrine Therapy Use
    Fleege, Nicole M. Grogan
    Li, Yajing
    Kidwell, Kelley M.
    Henry, N. Lynn
    [J]. CLINICAL BREAST CANCER, 2023, 23 (04) : 454 - 460
  • [47] Insights on adjuvant endocrine therapy for premenopausal and postmenopausal breast cancer
    Briest, Susanne
    Wolff, Antonio C.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (09) : 1243 - 1253
  • [48] Use of ovarian suppression with endocrine therapy among premenopausal women with breast cancer in the United States, 2001-2016
    Mayer, Sophie E.
    Lund, Jennifer L.
    Pate, Virginia
    Reeder-Hayes, Katherine E.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 545 - 546
  • [49] Use of ovarian suppression with endocrine therapy among premenopausal United States women with breast cancer, 2001-2016.
    Mayer, Sophie Emma
    Lund, Jennifer Leigh
    Pate, Virginia
    Reeder-Hayes, Katherine Elizabeth
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] Early Discontinuation of Endocrine Therapy and Recurrence of Breast Cancer among Premenopausal Women
    Collin, Lindsay J.
    Cronin-Fenton, Deirdre P.
    Ahern, Thomas P.
    Goodman, Michael
    McCullough, Lauren E.
    Waller, Lance A.
    Kjaersgaard, Anders
    Damkier, Per
    Christiansen, Peer M.
    Ejlertsen, Bent
    Jensen, Maj-Britt
    Sorensen, Henrik Toft
    Lash, Timothy L.
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (05) : 1421 - 1428
12345